Several studies report a change of the proBDNF/BDNF ratio in neurons or cerebrospinal fluid in diverse neurocognitive disorders such as Alzheimer’s disease (13, 14), major depressive disorder (8), autism (15), and affective disorders (4). The gene discussed is BDNF; the disease is autism.